Palantir Technologies Inc. - Class A Common Stock (PLTR)

Health and wellness products company USANA Health Sciences (NYSE:USNA) reported Q1 CY2026 results topping the market’s revenue expectations, but sales were f...

This biotech company develops therapies for neurodegenerative and rare diseases, supported by clinical assets and pharma collaborations.

Auto financing company Credit Acceptance (NASDAQ:CACC) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 44.8% year on ye...

The semiconductor and networking specialist is rising on strong results from another major AI player.

What Happened? Shares of data analytics company Palantir Technologies (NASDAQ:PLTR) fell 6.6% in the afternoon session after it reported first-quarter result...

What Happened? Shares of ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) fell 5.8% in the afternoon session after the company report...

Palantir stock tumbled Tuesday, giving Michael Burry fresh ammunition in his latest shot at the software and defense-AI favorite.

Palantir's 2026 first-quarter earnings results beat Wall Street estimates on both the top and bottom lines.

Palantir stock falls after a blowout Q1 earnings report as valuation concerns, analyst targets, and growth outlook drive investor debate

Nvidia stock hit a new all-time high in April, as investors flooded back into AI stocks. There could be more to come.

Palantir's Rule of 40 hits 145%, above SaaS norms, as growth + margins rise together—highlighting a rare efficiency surge beyond AI narrative.

What Happened? Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 20.3% in the morning session after it reported first-quarter 2026 re...

Palantir (PLTR) reports strong Q1 results with revenue of $1.63B and adjusted earnings of $0.33 per share. Analysts raise price targets.

Palantir analysts are mixed on first-quarter results, but see a strong long-term growth potential for the AI stock.

Palantir grew sales and quadrupled earnings in Q1. So why are investors selling?

Palantir (PLTR) posts its fastest growth since going public. Revenue hits $1.63B as AIP demand surges. Get the full Q1 earnings breakdown.

PLTR CEO said the company will prioritize U.S. national security over commercial clients as strong AI demand drives rapid growth.

Data analytics company Palantir Technologies (NASDAQ:PLTR) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 84.7% year on year to $1.63 bi...